# Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer

> **NCT00103831** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Oral Taxane

## Key facts

- **NCT ID:** NCT00103831
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103831, "Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00103831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*